Roflumilast reduces myocardial ischemia reperfusion injury in vivo and in vitro by activating the AMPK signaling pathway

Myocardial tissue cell damage induced by myocardial ischemia/reperfusion (MI/R) notably elevates the mortality rate, increases the complications of patients with myocardial infarction and decreases reperfusion benefit in patients suffering from acute myocardial infarction. Roflumilast protect agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Bo, Han, Zhongyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203911/
https://www.ncbi.nlm.nih.gov/pubmed/37229319
http://dx.doi.org/10.3892/etm.2023.12001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203911/
https://www.ncbi.nlm.nih.gov/pubmed/37229319
http://dx.doi.org/10.3892/etm.2023.12001

Ejemplares similares